Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Peter Mugyenyi"'
Autor:
Richard M. Gibson, Gabrielle Nickel, Michael Crawford, Fred Kyeyune, Colin Venner, Immaculate Nankya, Eva Nabulime, Emmanuel Ndashimye, Art F. Y. Poon, Robert A. Salata, Cissy Kityo, Peter Mugyenyi, Miguel E. Quiñones-Mateu, Eric J. Arts
Publikováno v:
Infectious Diseases of Poverty, Vol 6, Iss 1, Pp 1-13 (2017)
Abstract Background Thymidine analogs, namely AZT (Zidovudine or Retrovir™) and d4T (Stavudine or Zerit™) are antiretroviral drugs still employed in over 75% of first line combination antiretroviral therapy (cART) in Kampala, Uganda despite avers
Externí odkaz:
https://doaj.org/article/cc1b3016e85046149eaa13ef73e04de9
Autor:
Robert Gross, MD MSCE, Justin Ritz, MS, Michael D Hughes, ProfPhD, Robert Salata, ProfMD, Peter Mugyenyi, ProfFRCPE, Evelyn Hogg, BA, Linda Wieclaw, BA, Catherine Godfrey, MD, Carole L Wallis, PhD, John W Mellors, ProfMD, Victor O Mudhune, MPH, Sharlaa Badal-Faesen, MBBCh, Beatriz Grinsztejn, ProfMD, Ann C Collier, ProfMD
Publikováno v:
The Lancet: Digital Health, Vol 1, Iss 1, Pp e26-e34 (2019)
Summary: Background: Antiretroviral therapy (ART) non-adherence causes HIV treatment failure. Past behaviour might predict future behaviour; failing second-line ART could indicate ongoing risk for subsequent non-adherence. We aimed to find out whethe
Externí odkaz:
https://doaj.org/article/5a8c417eeec443e6a268bd650aac2d3d
Autor:
Colin M. Venner, Immaculate Nankya, Fred Kyeyune, Korey Demers, Cynthia Kwok, Pai-Lien Chen, Sandra Rwambuya, Marshall Munjoma, Tsungai Chipato, Josaphat Byamugisha, Barbara Van Der Pol, Peter Mugyenyi, Robert A. Salata, Charles S. Morrison, Eric J. Arts
Publikováno v:
EBioMedicine, Vol 13, Iss C, Pp 305-314 (2016)
Introduction: Long-term natural history cohorts of HIV-1 in the absence of treatment provide the best measure of virulence by different viral subtypes. Methods: Newly HIV infected Ugandan and Zimbabwean women (N = 303) were recruited and monitored fo
Externí odkaz:
https://doaj.org/article/95cd0c048d2042178700af91d38a92c4
Autor:
Katja Klein, Gabrielle Nickel, Immaculate Nankya, Fred Kyeyune, Korey Demers, Emmanuel Ndashimye, Cynthia Kwok, Pai-Lien Chen, Sandra Rwambuya, Art Poon, Marshall Munjoma, Tsungai Chipato, Josaphat Byamugisha, Peter Mugyenyi, Robert A Salata, Charles S Morrison, Eric J Arts
Publikováno v:
PLoS Pathogens, Vol 14, Iss 1, p e1006754 (2018)
In the majority of cases, human immunodeficiency virus type 1 (HIV-1) infection is transmitted through sexual intercourse. A single founder virus in the blood of the newly infected donor emerges from a genetic bottleneck, while in rarer instances mul
Externí odkaz:
https://doaj.org/article/7082ff27c4014f5f90eb047f7e4ce0ef
Autor:
Anchalee, Avihingsanon, Michael D, Hughes, Robert, Salata, Catherine, Godfrey, Caitlyn, McCarthy, Peter, Mugyenyi, Evelyn, Hogg, Robert, Gross, Sandra W, Cardoso, Aggrey, Bukuru, Mumbi, Makanga, Sharlaa, Badal-Aesen, Vidya, Mave, Beatrice Wangari, Ndege, Sandy Nerette, Fontain, Wadzanai, Samaneka, Rode, Secours, Marije, Van Schalkwyk, Rosie, Mngqibisa, Lerato, Mohapi, Javier, Valencia, Patcharaphan, Sugandhavesa, Esmelda, Montalban, Cornelius, Munyanga, Maganizo, Chagomerana, Breno R, Santos, Nagalingeswaran, Kumarasamy, Cecilia, Kanyama, Robert T, Schooley, John W, Mellors, Carole L, Wallis, Ann C, Collier, Beatriz, Grinsztejn
Publikováno v:
Journal of the International AIDS Society. 25
ACTG A5288 was a strategy trial conducted in diverse populations from multiple continents of people living with HIV (PLWH) failing second-line protease inhibitor (PI)-based antiretroviral therapy (ART) from 10 low- and middle-income countries (LMICs)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52dec7c1ab2a5a98c1631e9fb54babf6
https://doi.org/10.1002/jia2.25905
https://doi.org/10.1002/jia2.25905
Autor:
Peter Mugyenyi, Sharlaa Badal-Faesen, Beatriz Grinsztejn, Evelyn Hogg, John W. Mellors, Linda Wieclaw, Robert A. Salata, Justin Ritz, Carole L. Wallis, Ann C. Collier, Robert E. Gross, Catherine Godfrey, Victor Mudhune, Michael Hughes
Publikováno v:
The Lancet: Digital Health, Vol 1, Iss 1, Pp e26-e34 (2019)
Summary Background Antiretroviral therapy (ART) non-adherence causes HIV treatment failure. Past behaviour might predict future behaviour; failing second-line ART could indicate ongoing risk for subsequent non-adherence. We aimed to find out whether
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d48fd494e82e09f14324163f953537e8
https://doi.org/10.1016/s2589-7500(19)30006-8
https://doi.org/10.1016/s2589-7500(19)30006-8
Autor:
Cissy Kityo, Diana M Gibb, Charles F Gilks, Ruth L Goodall, Ivan Mambule, Pontiano Kaleebu, Deenan Pillay, Ronnie Kasirye, Peter Mugyenyi, A Sarah Walker, David T Dunn, DART Trial Team
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e90772 (2014)
In contrast to resource-rich countries, most HIV-infected patients in resource-limited countries receive treatment without virological monitoring. There are few long-term data, in this setting, on rates of viral suppression or switch to second-line a
Externí odkaz:
https://doaj.org/article/f6a20ff72864442e9f8448d36ce5a4d2
Autor:
Diana M Gibb, Peter Mugyenyi
Publikováno v:
The Lancet Global Health, Vol 2, Iss 1, Pp e4-e5 (2014)
Externí odkaz:
https://doaj.org/article/44c6ac5e93ab40d48f614f8823a52c82
Autor:
Charles F Gilks, A Sarah Walker, Paula Munderi, Cissy Kityo, Andrew Reid, Elly Katabira, Ruth L Goodall, Heiner Grosskurth, Peter Mugyenyi, James Hakim, Diana M Gibb, DART Virology Group and Trial Team
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e57580 (2013)
In low-income countries, viral load (VL) monitoring of antiretroviral therapy (ART) is rarely available in the public sector for HIV-infected adults or children. Using clinical failure alone to identify first-line ART failure and trigger regimen swit
Externí odkaz:
https://doaj.org/article/8782e243aafc40479de980755ce08916
Autor:
Antonieta Medina Lara, Jesse Kigozi, Jovita Amurwon, Lazarus Muchabaiwa, Barbara Nyanzi Wakaholi, Ruben E Mujica Mota, A Sarah Walker, Ronnie Kasirye, Francis Ssali, Andrew Reid, Heiner Grosskurth, Abdel G Babiker, Cissy Kityo, Elly Katabira, Paula Munderi, Peter Mugyenyi, James Hakim, Janet Darbyshire, Diana M Gibb, Charles F Gilks, DART Trial Team
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e33672 (2012)
Despite funding constraints for treatment programmes in Africa, the costs and economic consequences of routine laboratory monitoring for efficacy and toxicity of antiretroviral therapy (ART) have rarely been evaluated.Cost-effectiveness analysis was
Externí odkaz:
https://doaj.org/article/77a1520ae5834f208c0ebd0d9106a0b8